Technology Stocks & Market Talk With Don Wolanchuk Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk

SOXL 55.38

-1.2%

Jan 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

From: DrO	2/16/2023 9:31:55 AM
	6 Recommendations Read Replies (2) of 207821

As universities in the United States continue to mandate liability-free injections (COVID vaccines) for students at limited risk of contracting COVID, it becomes imperative that more public information be made available for the ingredients of these experimental vaccines. Both the EMA and the TGA have made note of fragmented RNA and smeary western blots suggesting the vaccine manufacturing process lacks fidelity and transparency. Shortly after the TGA data was released, Patel et al . (Pfizer) published a paper attempting to defuse these concerns. Jessica Rose has covered this topic here. Informed consent cannot be obtained with poorly characterized therapeutics. We are now entering the third year of COVID and its has become increasingly clear which demographics are at risk. The student age group (under 25) has repeatedly been shown to have very low risk of COVID yet the vaccine induced adverse events for students in this age bracket is higher than any vaccine ever administered. Krug et al. observed a risk of 1:6250 risk for myo/pericarditis in 16-17 year olds ( Krug et al). jessicar.substack.com anandamide.substack.com As universities in the United States continue to mandate liability-free injections (COVID vaccines) for students at limited risk of contracting COVID, it becomes imperative that more public information be made available for the ingredients of these experimental vaccines. Both the EMA and the TGA have made note of fragmented RNA and smeary western blots suggesting the vaccine manufacturing process lacks fidelity and transparency. Shortly after the TGA data was released, Patel et al . (Pfizer) published a paper attempting to defuse these concerns. Jessica Rose has covered this topic here. Informed consent cannot be obtained with poorly characterized therapeutics. We are now entering the third year of COVID and its has become increasingly clear which demographics are at risk. The student age group (under 25) has repeatedly been shown to have very low risk of COVID yet the vaccine induced adverse events for students in this age bracket is higher than any vaccine ever administered. Krug et al. observed a risk of 1:6250 risk for myo/pericarditis in 16-17 year olds ( Krug et al).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next